Edition:
India

Roche Holding AG (RO.S)

RO.S on Swiss Exchange

269.40CHF
19 Mar 2019
Change (% chg)

CHF0.20 (+0.07%)
Prev Close
CHF269.20
Open
CHF268.40
Day's High
CHF271.40
Day's Low
CHF268.40
Volume
19,443
Avg. Vol
35,266
52-wk High
CHF280.00
52-wk Low
CHF209.40

Chart for

About

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas:... (more)

Overall

Beta: 0.97
Market Cap(Mil.): CHF214,033.70
Shares Outstanding(Mil.): 862.56
Dividend: 8.20
Yield (%): 3.31

Financials

  RO.S Industry Sector
P/E (TTM): 22.03 29.30 32.54
EPS (TTM): 11.25 -- --
ROI: 20.46 14.23 13.82
ROE: 46.88 15.46 15.25

U.S. FDA approves Roche's small cell lung cancer treatment

March 18 Swiss drugmaker Roche Holding AG's U.S. unit Genentech said on Monday its immunotherapy Tecentriq won approval for a tough-to-treat type of lung cancer, the latest win for the drug whose sales trail medicines from Merck & Co and Bristol-Myers Squibb.

19 Mar 2019

Lilly's combo therapy succeeds in late-stage lung cancer study

Eli Lilly and Co's combination cancer treatment met the main goal of a late-stage clinical trial testing it on patients with a form of lung cancer, the drugmaker announced on Tuesday.

12 Mar 2019

Lilly's combo treatment meets main goal in lung cancer late-stage study

March 12 Eli Lilly and Co said on Tuesday that its combo treatment, Cyramza, met the main goal in a late-stage study in patients with a form of lung cancer.

12 Mar 2019

Wall Street rises after Trump stirs China trade hopes again

NEW YORK Wall Street's three major indexes ended higher on Monday but well below the session's highs after President Donald Trump said he would delay a planned hike in tariffs on Chinese imports. | Video

26 Feb 2019

Wall Street rises after Trump stirs China trade hopes again

NEW YORK Wall Street's three major indexes ended higher on Monday but well below the session's highs after President Donald Trump said he would delay a planned hike in tariffs on Chinese imports. | Video

26 Feb 2019

US STOCKS-Wall St rises after Trump stirs China trade hopes again

* Indexes up: Dow 0.23 pct, S&P 500 0.12 pct, Nasdaq 0.36 pct (Updates to close of trading, adds comments)

26 Feb 2019

US STOCKS-Trump talk that U.S.-China trade deal near pushes Wall St higher

* Indexes up: Dow 0.52 pct, S&P 500 0.37 pct, Nasdaq 0.56 pct (Updates to late afternoon, adds comments, changes byline, Adds New York dateline)

26 Feb 2019

Roche 'steps up' for gene therapy with $4.3 bln Spark bet

ZURICH Roche is buying U.S.-based gene therapy specialist Spark Therapeutics for $4.3 billion after developments in this area convinced the Swiss drugmaker to "step up", Chief Executive Severin Schwan said on Monday. | Video

25 Feb 2019

US STOCKS-Hopes of trade deal push Wall St higher

* Indexes up: Dow 0.59 pct, S&P 0.45 pct, Nasdaq 0.58 pct (Updates to early afternoon, adds comments)

25 Feb 2019

US STOCKS-Wall St climbs as trade optimism boosts tech, industrials

* Indexes up: Dow 0.79 pct, S&P 0.74 pct, Nasdaq 0.98 pct (Adds comments, details, updates prices)

25 Feb 2019

Earnings vs. Estimates